BERKEN IP is an Intellectual Property Law Firm focused on Patents, Technology & Business, located in Buenos Aires, Argentina. With a differential expertise in the areas of biotechnology, chemistry and pharmacy, it’s the “Firm of reference” concerning these fields.
The Firm’s practice encompasses a broad range of IP services aimed at protecting, managing, growing, enforcing and defending its clients’ IP assets in Argentina and abroad. These services are defined into three practice groups: Legal Affairs, Patent Intelligence & IP Prosecution.
BERKEN IP is staffed by an interdisciplinary team of experienced professionals with formal scientific, technical and legal training.
The Firm advises and serves local, foreign and international clients that range from big global companies to the scientific community, including universities, research and development centers, technology parks, incubators, technology-based entrepreneurs and start-up companies.
Contact Details
Av. Santa Fe 1863, Piso 1 I (C1123AAA) Buenos Aires, Argentina
Tel.: (54 11) 5252-2452 I Fax: (54 11) 5252-2453 / 4815-5985
info@berkenip.com I www.berkenip.com
The president of Denver Farma explains how crucial exports are for his company, especially to countries like Brazil where the market participation of local companies is small, and multinational companies…
Edgardo Vázquez, Pfizer’s country manager for the Argentina Region, discusses the company’s investment strategies across their newly established business units and a few of the unique challenges presented by the…
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. Could you provide a historical overview…
The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated generics. Could you please…
The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines and becoming a pure pharmaceutical company. …
The general director of pharma in Argentina for the Bagó group explains why his group has planned that 75 percent of turnover will come from international markets in the coming years. 2014 marks…
The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country’s ambitions in this area, which is to have an impact on innovation at…
The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you please provide an historical overview of Argenomics? Several…
The general manager of Ferring Argentina believes that the country has one of the strongest social security systems in Latin America, with high reimbursement levels and coverage for most chronic…
The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in the region for Roche, and…
The general manager of Gennoma Laboratorios Argentina weighs up the factors of why raising brand awareness using public television is the key success to his company communication strategy. When…
See our Cookie Privacy Policy Here
